RED BANK, N.J., Nov. 11, 2020 /PRNewswire/ -- Provention
Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company
dedicated to intercepting and preventing autoimmune disease, today
announced that management will present at the Stifel Virtual
Healthcare Conference on Wednesday, November
18, 2020, at 8:00 am E.T.
A webcast of the presentation can be accessed by visiting the
Events and Webcasts section of the Company's website:
http://investors.proventionbio.com/events. The webcast will be
archived on the Company's website for 90 days following the
presentation.
About Provention Bio, Inc.:
Provention Bio, Inc. (Nasdaq: PRVB) is a biopharmaceutical
company focused on advancing the development of investigational
therapies that may intercept and prevent debilitating and
life-threatening immune-mediated disease. The Company has submitted
a BLA to the FDA for its lead investigational drug candidate,
teplizumab, for the delay or prevention of clinical type 1 diabetes
(T1D) in at-risk individuals. The Company's pipeline includes
additional clinical-stage product candidates that have demonstrated
in pre-clinical or clinical studies proof-of-mechanism and/or
proof-of-concept in other autoimmune diseases, including celiac
disease and lupus. Visit www.proventionbio.com for more
information or follow us on Twitter: @Proventiobio
Internet Posting of Information:
Provention Bio, Inc. uses its
website, www.proventionbio.com, as a means of disclosing
material nonpublic information and for complying with its
disclosure obligations under Regulation FD. Such disclosures will
be included on the Company's website in the "News" section.
Accordingly, investors should monitor this portion of the Company's
website, in addition to following its press
releases, SEC filings and public conference calls and
webcasts.
Investor Contact:
Sam
Martin, Argot Partners
sam@argotpartners.com
212-600-1902
Media:
Lori Rosen, LDR
Communications
lori@ldrcommunications.com
917-553-6808
View original content to download
multimedia:http://www.prnewswire.com/news-releases/provention-bio-to-present-at-the-stifel-virtual-healthcare-conference-301170677.html
SOURCE Provention Bio, Inc.